MedTrace Logo

Effects of Red Grape Cells (RGC) Powder in Type 2 Diabetics

NCT01938521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-08-28

No results posted yet for this study

Summary

The aim of this study is to examine whether the chronic administration during 12 weeks of polyphenols contained in Red Grape Cells (RGC) powder has an effect on mRNA expression of SIRT1 and Clock Genes, on circulating levels of HbA1c, lipids, blood pressure and on postprandial response of glucose, lipids, insulin, C-peptide and GLP-1 in patients with type 2 diabetes .

Conditions

Interventions

DIETARY_SUPPLEMENT

Red Grape Cells (RGC)

Red Grape Cells (RGC) 1000 mg powder once daily by mouth for three month

DIETARY_SUPPLEMENT

Placebo (for Red Grape Cells (RGC))

Placebo (for Red Grape Cells (RGC)) powder manufactured to mimic Red Grape Cells (RGC) 1000 mg powder

Sponsors & Collaborators

  • Wolfson Medical Center

    collaborator OTHER_GOV

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Daniela Jakubowicz, MD · Diabetes Unit E. Wolfson Medical Center. Tel Aviv University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-02-28
Completion
2017-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938521 on ClinicalTrials.gov